Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 32: 386-388, 1986;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goren, M. P.
Right arrow Articles by Li, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goren, M. P.
Right arrow Articles by Li, J. T.

Clinical Chemistry, Vol 32, 386-388, Copyright © 1986 by American Association for Clinical Chemistry

The Coomassie Brilliant Blue method underestimates drug-induced tubular proteinuria

MP Goren and JT Li

The sensitivity of the Coomassie Brilliant Blue (CBB) procedure differs for different proteins. To investigate the impact of this variability on clinical measurements of proteinuria, we collected urine specimens from patients with glomerular disease or drug-induced tubular nephrotoxicity and compared urinary protein concentrations as determined by the CBB method with those obtained by the biuret method. The CBB method underestimated the protein concentration predicted by the biuret method by as much as eightfold in specimens with low proportions of albumin. Determinations of protein by the CBB method in serially diluted urine specimens from patients with tubular damage also deviated from linearity by as much as twofold for protein concentrations less than 1 g/L. We conclude that CBB binding is relatively insensitive for measuring proteins specifically associated with tubular damage and hence may be inappropriate for clinical use.


The following articles in journals at HighWire Press have cited this article:


Home page
 Ann Clin BiochemHome page
E. J Lamb, F. MacKenzie, and P. E Stevens
How should proteinuria be detected and measured?
Ann Clin Biochem, May 1, 2009; 46(3): 205 - 217.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
P. L. Tugirimana and J. R. Delanghe
Development of an affordable dye-stained microalbuminuria screening test
Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1485 - 1490.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Leanos-Miranda, J. Marquez-Acosta, F. Romero-Arauz, G. M. Cardenas-Mondragon, R. Rivera-Leanos, I. Isordia-Salas, and A. Ulloa-Aguirre
Protein:Creatinine Ratio in Random Urine Samples Is a Reliable Marker of Increased 24-Hour Protein Excretion in Hospitalized Women with Hypertensive Disorders of Pregnancy
Clin. Chem., September 1, 2007; 53(9): 1623 - 1628.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
T. Marshall and K. M. Williams
Total Protein Determination in Urine: Elimination of a Differential Response between the Coomassie Blue and Pyrogallol Red Protein Dye-binding Assays
Clin. Chem., March 1, 2000; 46(3): 392 - 398.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the American Association for Clinical Chemistry.